EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 390 filers reported holding EXELIXIS INC in Q3 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,707,128 | +14.3% | 123,896 | 0.0% | 0.22% | +19.0% |
| Q2 2023 | $2,367,653 | -1.5% | 123,896 | 0.0% | 0.19% | -4.5% |
| Q1 2023 | $2,404,821 | +72.1% | 123,896 | +42.2% | 0.20% | +69.2% |
| Q4 2022 | $1,397,357 | -10.3% | 87,117 | -12.3% | 0.12% | -11.4% |
| Q3 2022 | $1,558,000 | -24.7% | 99,343 | 0.0% | 0.13% | -18.5% |
| Q2 2022 | $2,068,000 | -8.2% | 99,343 | 0.0% | 0.16% | +18.2% |
| Q1 2022 | $2,252,000 | +24.0% | 99,343 | 0.0% | 0.14% | +41.2% |
| Q4 2021 | $1,816,000 | -13.5% | 99,343 | 0.0% | 0.10% | -19.2% |
| Q3 2021 | $2,100,000 | +16.0% | 99,343 | 0.0% | 0.12% | +17.6% |
| Q2 2021 | $1,810,000 | -16.6% | 99,343 | +3.4% | 0.10% | -20.3% |
| Q1 2021 | $2,171,000 | +12.5% | 96,115 | +0.0% | 0.13% | +9.4% |
| Q4 2020 | $1,929,000 | – | 96,090 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 15,001,073 | $265,294,000 | 64.62% |
| Sargent Investment Group, LLC | 465,620 | $8,234,000 | 3.70% |
| Orbimed Advisors | 3,912,900 | $69,200,000 | 1.31% |
| Bellevue Group AG | 3,858,700 | $68,241,000 | 1.27% |
| TEALWOOD ASSET MANAGEMENT INC | 137,129 | $2,425,000 | 1.04% |
| CAPITAL MANAGEMENT CORP /VA | 200,995 | $3,555,000 | 0.97% |
| Penn Capital Management Company, LLC | 517,988 | $9,161,000 | 0.96% |
| Chicago Capital, LLC | 801,560 | $14,176,000 | 0.95% |
| Portolan Capital Management | 454,444 | $8,037,000 | 0.91% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 103,534 | $1,830,000 | 0.85% |